Some older women may not benefit from annual breast cancer screenings, according to a study published Aug. 8 in Annals of Internal Medicine. Continued mammograms after age 70 may cause what researchers labeled "overdiagnosis" of the disease.

Leading a team of oncology clinicians to propel patient success stories is no small feat, especially in a reality where 35 percent of these professionals take on extra work due to demand.

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the fewest emergency department visits for patients receiving outpatient chemotherapy, CMS found.

A small gland in the throat known as the thymus may aid with fighting cancer and other causes of death, the Harvard Gazette reported Aug. 2. 

Massachusetts Institute of Technology researchers developed an ultrasound device that can detect early-stage breast tumors in between routine mammograms, according to a July 23 news release from MIT News. 

Seattle-based Fred Hutchinson Cancer Institute had the lowest admission rate following outpatient chemotherapy treatment, CMS found.

Cancer patients and oncology clinicians continue to grapple with an ongoing national drug shortage that is now affecting 57 percent of hospital pharmacies, according to an American Society of Health-System Pharmacists poll published Aug. 10. 

Texas Tech University Health Sciences Center El Paso received a $25 million gift from the Fox Family Foundation to help build West Texas' first comprehensive cancer center.

Five cancer hospitals received a perfect score from CMS for moderate-to-severe pain care plans.

An AI-powered machine learning tool may allow physicians to better identify origins in enigmatic cancers, according to researchers at the Massachusetts Institute of Technology in Cambridge, Mass., and Dana-Farber Cancer Institute in Boston. 

Eleven newly named researchers will be the first group to embark on President Joe Biden's Cancer Moonshot, sharing $5.4 million in scholarships to "fight to end cancer as we know it," according to an Aug. 3 White House news release.

Cost-Saving Robotic Tech Bringing World-Class Care to >90% of Cancer Patients Who Currently Lack Access

Detroit-based Barbara Ann Karmanos Cancer Institute, a McLaren Health Care-owned facility, has named Boris Pasche, MD, PhD, as the center's new president and CEO, according to an Aug. 7 news release.

Three more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.

Here are stories covering recent research, treatment, strategy and moves from some of the nation's top cancer hospitals:

While still in contract negotiations, registered nurses at Dana-Farber Cancer Institute - Merrimack Valley in Methuen, Mass., voted 33 to 1 to authorize a one-day strike, the Massachusetts Nurses Association said in an NBC Boston report. 

Researchers at Los Angeles-based City of Hope recently announced promising results for a new chemotherapy pill that "appears to annihilate all solid tumors," according to research published Aug. 1 in Cell Chemical Biology. 

The FDA approved GSK's Jemperli (dostarlimab) in combination with carboplatin and paclitaxel for adults with primary advanced or recurrent endometrial cancer who are mismatch repair deficient or microsatellite instability-high.

The University of Texas MD Anderson Cancer Center in Houston earned the No. 1 spot on U.S. News & World Report's "2023-24 Best Hospitals for Cancer" rankings, released Aug. 1. 

Eleven major cancer centers, or health systems with notable ones, have made Forbes' 2023 list of best places to work in the U.S. for women.